Adults consuming whole grain rye have lower plasma serotonin levels than people eating low-fibre wheat bread, according to a recent study by the University of Eastern Finland and the International Agency for Research on Cancer (IARC). 

Preliminary laboratory tests show that functionalized magnetic beads successfully reduced blood levels of a harmful molecule that is elevated during preeclampsia, according to new research in the American Heart Association’s journal Hypertension.

Harnessing the body’s immune system to fight off cancer, a tactic known as immunotherapy, has tremendously improved outcomes for patients.

Would you trust a robot to diagnose your cancer? 

A new therapy to re-engage the heart’s natural electrical pathways – instead of bypassing them – could mean more treatment options for heart failure patients who also suffer from electrical disturbances, such as arrhythmias, according to research led by the University of Chicago Medicine.

In the February 11 issue of Nature Sustainability, a multi-institution team unveiled a new tool for understanding and controlling the health and climate impacts of shipping goods – a source not only of greenhouse gases but of soot and smog threatening our health.

Buildings of the future may be lit by collections of glowing plants and designed around an infrastructure of sunlight harvesting, water transport, and soil collecting and composting systems.

Researchers at Washington State University have created a new, genetically distinct variety of wheat that’s safer for people with celiac disease, opening the door for new treatments and healing potential for the staple grain.

Neurobiologists at the University of California San Diego have pinpointed the brain area responsible for value decisions that are made based on past experiences.

Newly identified subsets of cell types present in joint tissue in people with rheumatoid arthritis and how they interact may explain why only some people respond to existing medications, according to two studies by co-senior author Laura Donlin, PhD, Co-Director of the Derfner Foundation Precision Medicine Laboratory at Hospital for Special Surgery (HSS) and collaborating colleagues.